KIG
BHC icon

Kessler Investment Group’s Bausch Health BHC Stock Holding History

Kessler Investment Group’s Portfolio BHC Stock Details BHC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-3,900
Closed -$103K – 91
2016
Q1 		$103K Buy
+3,900
New +$288K 0.16% 59

Other funds holding BHC

PSCM
Pershing Square Capital Management New York $13.7B AUM 13.45% 1-Year Est. Return
PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VH
ValueAct Holdings San Francisco, California $5.71B AUM 7.41% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $69.7B AUM 40.86% 1-Year Est. Return
DSA
Davis Selected Advisers Tucson, Arizona $21.8B AUM 23.45% 1-Year Est. Return
Nomura Holdings
Nomura Holdings Tokyo, Japan $37.7B AUM 34.44% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Kessler Investment Group's BHC Position: Q2 2016 in Review

Kessler Investment Group sold out of Bausch Health (BHC) in Q2 2016, closing a stake of 3,900 shares — an estimated $103K sold.

Kessler Investment Group first reported a position in BHC in Q1 2016 and held it in 1 quarter. The position peaked at $103K in Q1 2016. 347 funds tracked by Wall St. Rank hold BHC as of Q2 2016.

  • Kessler Investment Group reported no remaining Bausch Health position as of Q2 2016 after selling out during the quarter.
  • Kessler Investment Group sold 3,900 Bausch Health shares in Q2 2016, an estimated $103K.
  • Kessler Investment Group first reported a position in Bausch Health in Q1 2016 and held it in 1 quarter.
  • Kessler Investment Group's Bausch Health position peaked at $103K in Q1 2016.
  • 347 funds tracked by Wall St. Rank held Bausch Health as of Q2 2016.

Based on Kessler Investment Group's 13F filing for Q2 2016, filed 19 Jul 2016.